Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Recruitment

Liftstream is an executive search recruitment company in the life sciences sector

Nominations Committees’ Resolutions Series: #5 – The Importance of Improving Shareholder Communication

Open and effective communication regarding director appointments, executive committee appointments, succession plans, nomination governance and process, board evaluations, will all boosts transparency and good governance recognition which strengthen shareholders’ trust. Whichever communication approach, nominations committees should reassure shareholders of the sustainability of the board and executive management by disclosing relevant information.live streaming film Underworld: Blood Wars 2016

Read the full article…

Posted in Corporate Governance | Tagged , , , , , , , , , , , , , | Leave a comment

Alnylam Elects Chairman and Board Member

Alnylam Pharmaceuticals, a biopharmaceutical company headquartered in Cambridge, Mass, has named Michael Bonney as Chairman to replace John Clarke who stepped down after 13 years of service. Clarke will remain on the board as a director of the company. Bonny is the current board member and former CEO of Cubist Pharmaceuticals.

Read the full article…

Posted in Board Director Appointments | Tagged , , , , , , , , , | Leave a comment

Ipsen secures development platform with Syntaxin Purchase

Authored by James Sheppard

Read the full article…

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Soaring biotech equity heightens recruitment challenges

Authored by Karl Simpson

Read the full article…

Posted in M&A Finance and Funding, Pharmaceutical business, Recruitment Market | Tagged , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Valeant Pharmaceuticals seeing Ophthalmology future

Authored by James Sheppard

Read the full article…

Posted in M&A Finance and Funding, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , | Leave a comment

Allergan Adds Migraine Treatment with purchase of MAP Pharmaceuticals

Allergan today (23/1/13) said that it would buy US based MAP Pharmaceuticals in a $958m acquisition. Allergan is purchasing MAP Pharmaceuticals in cash and has paid a 60% premium on the closing share price of MAP. Allergan expects the deal to dilute 2013 earnings by about 7 cents a share and begin to add revenue in H2 2014. The purchase follows on from a collaboration agreement Allergan and MAP made in January 2011 to co-promote Levadex in the US and Canada.

Read the full article…

Posted in Pharmaceutical business | Tagged , , , , , , , , , , , | 1 Comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap